Equillium (EQ) Return on Equity [ROE] (2018 - 2026)
Equillium (EQ) reported Return on Equity [ROE] of -31.07% for Q2 2026, up 233.00 percentage points from -264.08% a year earlier and up 12.99 percentage points from the prior quarter.
Equillium (EQ) Return on Equity [ROE] (2018 - 2026) Analysis & Trends
For FY2025, Equillium posted Return on Equity [ROE] of -93.99%, down 55.06 percentage points from FY2024.
- Return on Equity [ROE] has a five-year change of -39.97 percentage points (FY2020 to FY2025).
- By year, Return on Equity [ROE] came in at -38.94% in FY2024 (+10.06 pp), -49.00% in FY2023 (+77.83 pp), -126.83% in FY2022 (-69.91 pp) and -56.91% in FY2021 (-2.89 pp).
- The Q2 2026 figure ranks as the highest quarterly Return on Equity [ROE] since Q3 2024.
- Year over year, Return on Equity [ROE] gained in four of the last eight quarters, with an average year-over-year change of -13.41 percentage points.
- The high point for year-over-year Return on Equity [ROE] in five years was Q2 2026 (a gain of 233.00 percentage points); the low point was Q2 2025 (a drop of 225.91 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -44.06% (Q1 2026), -76.60% (Q4 2025) and -138.77% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Equillium | 181.13 Mn | 181.13 Mn | - | -31.07% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -31.07% |
| Mar 31, 2026 | -44.06% |
| Dec 31, 2025 | -76.60% |
| Sep 30, 2025 | -138.77% |
| Jun 30, 2025 | -264.08% |
| Mar 31, 2025 | -94.94% |
| Dec 31, 2024 | -38.38% |
| Sep 30, 2024 | -20.17% |
| Jun 30, 2024 | -38.16% |
| Mar 31, 2024 | -55.50% |
| Dec 31, 2023 | -57.25% |
| Sep 30, 2023 | -32.35% |
| Jun 30, 2023 | -64.73% |
| Mar 31, 2023 | -94.72% |
| Dec 31, 2022 | -207.74% |
| Sep 30, 2022 | -221.68% |
| Jun 30, 2022 | -155.67% |
| Mar 31, 2022 | -112.95% |
| Dec 31, 2021 | -54.53% |
| Sep 30, 2021 | -46.52% |
Equillium Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=EQ&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "EQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=EQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();